Qube Research & Technologies Ltd - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 68 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,858
-95.7%
6,091
-90.1%
0.00%
Q2 2023$43,47561,7540.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 217,029$2,225,0006.42%
Knoll Capital Management, LLC 350,238$3,590,0003.29%
INTERWEST VENTURE MANAGEMENT CO 764,918$7,840,0003.01%
Broadfin Capital, LLC 1,367,377$14,016,0002.59%
P.A.W. CAPITAL CORP 200,000$2,050,0002.56%
683 Capital Management, LLC 1,860,529$19,071,0002.12%
EcoR1 Capital, LLC 1,060,043$10,865,0001.37%
MANGROVE PARTNERS IM, LLC 847,284$8,685,0001.05%
KNOTT DAVID M 234,448$2,403,0001.01%
Trellus Management Company, LLC 85,000$871,0000.87%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders